NM_014956.5:c.1409+10G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1
The NM_014956.5(CEP164):c.1409+10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000778 in 1,594,850 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00035 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000049 ( 0 hom. )
Consequence
CEP164
NM_014956.5 intron
NM_014956.5 intron
Scores
2
Splicing: ADA: 0.0001117
2
Clinical Significance
Conservation
PhyloP100: -1.96
Publications
0 publications found
Genes affected
CEP164 (HGNC:29182): (centrosomal protein 164) This gene encodes a centrosomal protein involved in microtubule organization, DNA damage response, and chromosome segregation. The encoded protein is required for assembly of primary cilia and localizes to mature centrioles. Defects in this gene are a cause of nephronophthisis-related ciliopathies. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
CEP164 Gene-Disease associations (from GenCC):
- ciliopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- nephronophthisis 15Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, G2P
- Senior-Loken syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 11-117380715-G-A is Benign according to our data. Variant chr11-117380715-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 473078.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000355 (54/152210) while in subpopulation AFR AF = 0.0013 (54/41456). AF 95% confidence interval is 0.00102. There are 1 homozygotes in GnomAd4. There are 21 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CEP164 | NM_014956.5 | c.1409+10G>A | intron_variant | Intron 12 of 32 | ENST00000278935.8 | NP_055771.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CEP164 | ENST00000278935.8 | c.1409+10G>A | intron_variant | Intron 12 of 32 | 1 | NM_014956.5 | ENSP00000278935.3 | |||
| CEP164 | ENST00000533675.5 | n.1664+1G>A | splice_donor_variant, intron_variant | Intron 8 of 26 | 2 | |||||
| CEP164 | ENST00000533706.5 | n.733+10G>A | intron_variant | Intron 5 of 26 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000355 AC: 54AN: 152210Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
54
AN:
152210
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000105 AC: 23AN: 219088 AF XY: 0.0000851 show subpopulations
GnomAD2 exomes
AF:
AC:
23
AN:
219088
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000485 AC: 70AN: 1442640Hom.: 0 Cov.: 30 AF XY: 0.0000433 AC XY: 31AN XY: 715812 show subpopulations
GnomAD4 exome
AF:
AC:
70
AN:
1442640
Hom.:
Cov.:
30
AF XY:
AC XY:
31
AN XY:
715812
show subpopulations
African (AFR)
AF:
AC:
56
AN:
33136
American (AMR)
AF:
AC:
0
AN:
42306
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25754
East Asian (EAS)
AF:
AC:
0
AN:
39074
South Asian (SAS)
AF:
AC:
0
AN:
83072
European-Finnish (FIN)
AF:
AC:
0
AN:
52070
Middle Eastern (MID)
AF:
AC:
0
AN:
4750
European-Non Finnish (NFE)
AF:
AC:
2
AN:
1102868
Other (OTH)
AF:
AC:
12
AN:
59610
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000355 AC: 54AN: 152210Hom.: 1 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74362 show subpopulations
GnomAD4 genome
AF:
AC:
54
AN:
152210
Hom.:
Cov.:
32
AF XY:
AC XY:
21
AN XY:
74362
show subpopulations
African (AFR)
AF:
AC:
54
AN:
41456
American (AMR)
AF:
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5192
South Asian (SAS)
AF:
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
0
AN:
68038
Other (OTH)
AF:
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Nephronophthisis 15 Benign:2
Jan 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 06, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.